Further investigations revealed that TMEM158 enhanced glioma cell proliferation, migration, and invasion as well as the progression of epithelial mesenchymal transition (EMT) by activating STAT3 signaling in vitro as well as in a mouse model (15). The gene discussed is STAT3; the disease is central nervous system cancer.